Chair experimental immunobiology of cancer for Karin de Visser


At the Leiden University Medical Center (LUMC) she will focus on research into how the immune system influences the formation of metastases and the effectiveness of cancer treatments, with a focus on breast cancer.

Karin de Visser has been appointed on behalf of the Netherlands Cancer Institute in Amsterdam and remains head of her research group within the Tumour Biology & Immunology Department.


This site uses cookies

This website uses cookies to ensure you get the best experience on our website.